Integrins αvβ3 and α 4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1

Journal of Immunology

Volumn 189, Issue 12, 2012, Pages 5809-5819

  Fujita, Masaaki ^a   Takada, Yoko K ^a   Takada, Yoshikazu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; VERY LATE ACTIVATION ANTIGEN 4; VITRONECTIN RECEPTOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL INFILTRATION; COMPLEX FORMATION; CONTROLLED STUDY; LEUKOCYTE MIGRATION; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RESIDUE ANALYSIS; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CHEMOKINE CX3CL1; CHEMOKINES; CHO CELLS; COMPUTER SIMULATION; CRICETINAE; CRICETULUS; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRIN ALPHAVBETA3; K562 CELLS; MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOKINE; RECEPTORS, HIV; SIGNAL TRANSDUCTION; U937 CELLS;

EID: 84871119591     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200889     Document Type: Article

References (62)

1. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314. (Pubitemid 24046692)
2. Lloyd, A. R., J. J. Oppenheim, D. J. Kelvin, and D. D. Taub. 1996. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J. Immunol. 156: 932-938. (Pubitemid 26048084)
3. Ley, K., and T. F. Tedder. 1995. Leukocyte interactions with vascular endothelium: new insights into selectin-mediated attachment and rolling. J. Immunol. 155: 525-528.
4. Tedder, T. F., D. A. Steeber, A. Chen, and P. Engel. 1995. The selectins: vascular adhesion molecules. FASEB J. 9: 866-873.
5. Bargatze, R. F., and E. C. Butcher. 1993. Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules. J. Exp. Med. 178: 367-372. (Pubitemid 23173274)
6. Charo, I. F., and R. M. Ransohoff. 2006. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354: 610-621. (Pubitemid 43209108)
7. Tanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361: 79-82. (Pubitemid 23020778)
8. + T cells in response to MIP-1α and MIP-1β. Science 260: 355-358.
9. Taub, D. D., A. R. Lloyd, K. Conlon, J. M. Wang, J. R. Ortaldo, A. Harada, K. Matsushima, D. J. Kelvin, and J. J. Oppenheim. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177: 1809-1814. (Pubitemid 23146150)
10. Campbell, J. J., J. Hedrick, A. Zlotnik, M. A. Siani, D. A. Thompson, and E. C. Butcher. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279: 381-384. (Pubitemid 28063373)
11. Fong, A. M., L. A. Robinson, D. A. Steeber, T. F. Tedder, O. Yoshie, T. Imai, and D. D. Patel. 1998. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188: 1413-1419. (Pubitemid 28489578)
12. Pan, Y., C. Lloyd, H. Zhou, S. Dolich, J. Deeds, J. A. Gonzalo, J. Vath, M. Gosselin, J. Ma, B. Dussault, et al. 1997. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387: 611-617. (Pubitemid 27248766)
13. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640-644.
14. Umehara, H., E. T. Bloom, T. Okazaki, Y. Nagano, O. Yoshie, and T. Imai. 2004. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler. Thromb. Vasc. Biol. 24: 34-40. (Pubitemid 38082409)
15. Garton, K. J., P. J. Gough, C. P. Blobel, G. Murphy, D. R. Greaves, P. J. Dempsey, and E. W. Raines. 2001. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 276: 37993-38001.
16. Chapman, G. A., K. Moores, D. Harrison, C. A. Campbell, B. R. Stewart, and P. J. Strijbos. 2000. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. 20: RC87.
17. Hundhausen, C., D. Misztela, T. A. Berkhout, N. Broadway, P. Saftig, K. Reiss, D. Hartmann, F. Fahrenholz, R. Postina, V. Matthews, et al. 2003. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102: 1186-1195. (Pubitemid 36988021)
18. Imai, T., K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T. J. Schall, and O. Yoshie. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521-530. (Pubitemid 27508241)
19. Lucas, A. D., C. Bursill, T. J. Guzik, J. Sadowski, K. M. Channon, and D. R. Greaves. 2003. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation 108: 2498-2504. (Pubitemid 37444412)
20. Schäfer, A., C. Schulz, M. Eigenthaler, D. Fraccarollo, A. Kobsar, M. Gawaz, G. Ertl, U. Walter, and J. Bauersachs. 2004. Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. Blood 103: 407-412. (Pubitemid 38140067)
21. Goda, S., T. Imai, O. Yoshie, O. Yoneda, H. Inoue, Y. Nagano, T. Okazaki, H. Imai, E. T. Bloom, N. Domae, and H. Umehara. 2000. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J. Immunol. 164: 4313-4320. (Pubitemid 30215094)
22. Hynes, R. O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687. (Pubitemid 35283958)
23. Luo, B. H., C. V. Carman, and T. A. Springer. 2007. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25: 619-647.
24. Weber, C. 2003. Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules. J. Mol. Med. 81: 4-19. (Pubitemid 36207879)
25. Smith, M. L., T. S. Olson, and K. Ley. 2004. CXCR2- and E-selectin-induced neutrophil arrest during inflammation in vivo. J. Exp. Med. 200: 935-939. (Pubitemid 39362929)
26. Smith, D. F., E. Galkina, K. Ley, and Y. Huo. 2005. GRO family chemokines are specialized for monocyte arrest from flow. Am. J. Physiol. Heart Circ. Physiol. 289: H1976-H1984. (Pubitemid 41507347)
27. Weber, K. S., P. von Hundelshausen, I. Clark-Lewis, P. C. Weber, and C. Weber. 1999. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur. J. Immunol. 29: 700-712. (Pubitemid 29078533)
28. Moser, B., and P. Loetscher. 2001. Lymphocyte traffic control by chemokines. Nat. Immunol. 2: 123-128. (Pubitemid 33707929)
29. Gerard, C., and B. J. Rollins. 2001. Chemokines and disease. Nat. Immunol. 2: 108-115. (Pubitemid 33707927)
30. Haskell, C. A., M. D. Cleary, and I. F. Charo. 1999. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction: rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J. Biol. Chem. 274: 10053-10058.
31. Lauro, C., M. Catalano, F. Trettel, F. Mainiero, M. T. Ciotti, F. Eusebi, and C. Limatola. 2006. The chemokine CX3CL1 reduces migration and increases adhesion of neurons with mechanisms dependent on the b1 integrin subunit. J. Immunol. 177: 7599-7606. (Pubitemid 44846274)
32. Kerfoot, S. M., S. E. Lord, R. B. Bell, V. Gill, S. M. Robbins, and P. Kubes. 2003. Human fractalkine mediates leukocyte adhesion but not capture under physiological shear conditions; a mechanism for selective monocyte recruitment. Eur. J. Immunol. 33: 729-739. (Pubitemid 36367676)
33. Takagi, J., H. P. Erickson, and T. A. Springer. 2001. C-terminal opening mimics "inside-out" activation of integrin α5β1. Nat. Struct. Biol. 8: 412-416. (Pubitemid 32381287)
34. Tam, S. H., P. M. Sassoli, R. E. Jordan, and M. T. Nakada. 1998. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and αvβ3 integrins. Circulation 98: 1085-1091. (Pubitemid 28420700)
35. 1 integrin heterodimers mediate cell attachment to distinct sites on laminin. J. Cell Biol. 110: 2175-2184.
36. 1 subunit using activating and inhibiting antibodies. J. Biol. Chem. 268: 17597-17601.
37. 5 subunits. EMBO J. 14: 5550-5556.
38. 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor a5b1. J. Cell Biol. 127: 1129-1137.
39. 1 and induces proliferation of monocytic cells in an integrin-dependent manner. J. Biol. Chem. 283: 26107-26115.
40. 3 is involved in IGF-1 signaling. J. Biol. Chem. 284: 24106-24114.
41. 3 to FGF1 plays a role in FGF1 signaling. J. Biol. Chem. 283: 18066-18075.
42. Mizoue, L. S., S. K. Sullivan, D. S. King, T. N. Kledal, T. W. Schwartz, K. B. Bacon, and T. M. Handel. 2001. Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine. J. Biol. Chem. 276: 33906-33914.
43. Harrison, J. K., A. M. Fong, P. A. Swain, S. Chen, Y. R. Yu, M. N. Salafranca, W. B. Greenleaf, T. Imai, and D. D. Patel. 2001. Mutational analysis of the fractalkine chemokine domain: basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesion. J. Biol. Chem. 276: 21632-21641.
44. Aumailley, M., M. Gurrath, G. Müller, J. Calvete, R. Timpl, and H. Kessler. 1991. Arg-Gly-Asp constrained within cyclic pentapeptides: strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett. 291: 50-54.
45. 3 integrins by swapping a short diverse sequence of the b subunit. J. Biol. Chem. 272: 19794-19800.
46. 3 in complex with an Arg-Gly-Asp ligand. Science 296: 151-155.
47. 3, but do not require the RGD sequence of the CAV-9 VP1 protein. Hum. Immunol. 61: 453-459.
48. 3 to the fibrinogen gamma and α E chain C-terminal domains. Biochemistry 38: 5872-5877.
49. 4) is involved in neuregulin-1/ErbB signaling. J. Biol. Chem. 285: 31388-31398.
50. Harrison, J. K., Y. Jiang, S. Chen, Y. Xia, D. Maciejewski, R. K. McNamara, W. J. Streit, M. N. Salafranca, S. Adhikari, D. A. Thompson, et al. 1998. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. USA 95: 10896-10901. (Pubitemid 28413165)
51. Ruoslahti, E. 1991. Integrins. J. Clin. Invest. 87: 1-5.
52. Humphries, M. J. 1990. The molecular basis and specificity of integrin-ligand interactions. J. Cell Sci. 97: 585-592.
53. 1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. J. Biol. Chem. 269: 27224-27230.
54. + cells on vascular endothelium under shear flow. J. Clin. Invest. 104: 1199-1211.
55. + cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95: 3289-3296.
56. Sanz-Rodríguez, F., A. Hidalgo, and J. Teixidó. 2001. Chemokine stromal cell-derived factor-1α modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood 97: 346-351. (Pubitemid 32060316)
57. Potter, P. K., J. Cortes-Hernandez, P. Quartier, M. Botto, and M. J. Walport. 2003. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J. Immunol. 170: 3223-3232. (Pubitemid 36302200)
58. Puzon-McLaughlin, W., T. Kamata, and Y. Takada. 2000. Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin αIIbβ3. J. Biol. Chem. 275: 7795-7802. (Pubitemid 30159685)
59. 3 activation. Proc. Natl. Acad. Sci. USA 101: 13114-13120.
60. Kawaguchi, M., R. Hosotani, S. Ohishi, N. Fujii, S. S. Tulachan, M. Koizumi, E. Toyoda, T. Masui, S. Nakajima, S. Tsuji, et al. 2001. A novel synthetic Arg-Gly-Asp-containing peptide cyclo(-RGDf==V-) is the potent inhibitor of angiogenesis. Biochem. Biophys. Res. Commun. 288: 711-717. (Pubitemid 33030088)
61. Nanki, T., Y. Urasaki, T. Imai, M. Nishimura, K. Muramoto, T. Kubota, and N. Miyasaka. 2004. Inhibition of fractalkine ameliorates murine collagen-induced arthritis. J. Immunol. 173: 7010-7016. (Pubitemid 39541090)
62. Suzuki, F., T. Nanki, T. Imai, H. Kikuchi, S. Hirohata, H. Kohsaka, and N. Miyasaka. 2005. Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL/J mice. J. Immunol. 175: 6987-6996. (Pubitemid 41598945)